Melinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the United States

World News: . []

Approved for adult patients with acute bacterial skin and skin structure infections ABSSSI Provides coverage of gram-positive and gram-negative pathogens only FDA-approved fluoroquinolone for methicillin-resistant MRSA Inter changea...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 12:00 GMT Monday 29th January 2018

Published: .

Search for other references to "melinta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us